Profound Medical Corp. Insider Trading

PROF

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in May 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

May 2025

May 16, 2025

Get an email when PROF's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 15, 2025 – May 16, 2025	Arun Swarup Menawat CEO	Bought 2 parts	22,030	$4.55 average	100K	3.9%	Form 4

May 15, 2025 – May 16, 2025
Arun Swarup Menawat
CEO · bought 22,030 at avg $4.55
100K
3.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PROF, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PROF

CompareIntrinsic value

SNOASonoma Pharmaceuticals Inc.

$1.11-2.63%40

SRTSSensus Healthcare Inc.

$3.25-1.07%18

NEPHNephros Inc.

$3.25+0.31%54

VVOSVivos Therapeutics, Inc.

$0.11+0.91%26

DRIODarioHealth Corp.

$2.97-1.00%25

BTCYBiotricity Inc.

$0.06+1.29%64

MDAISpectral AI Inc.

$1.53+2.00%10

ALURAllurion Technologies Inc.

$0.02+0.00%10

Spot a number that looks wrong? Check it in PROF's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PROF

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.